Business
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development, effective July 1, 2025. "We are delighted to welcome Eric to the executive team,” said Thomas Zindrick, President, CEO, and Chairman of the Board. “Eric brings a powerful blend of legal expertise, global busines
About this update from Genelux Corporation
[{"type":"image","alt":"Genelux Corporation","displaySize":"","headline":null,"caption":"Genelux Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":75,"url":"https://media.zenfs.com/en/globenewswire.com/555a19f80dbf3a9d98dbd557739b10ea"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PqbnzpB7NuWaPPuiKZD5BA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/555a19f80dbf3a9d98dbd557739b10ea","width":300,"height":75}},"lazy":false},{"type":"image","alt":"Eric Groen, new General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development at Genelux","displaySize":"","headline":null,"caption":"Eric Groen, new General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development at Genelux","className":"","disableSlideshowImg":false,"size":{"original":{"width":208,"height":277,"url":"https://media.zenfs.com/en/globenewswire.com/22cfd9e8ccd361bb448be3529e6d1d6f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yQPFs1uPJYQPWWE.UOIQXA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTQ3OTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/22cfd9e8ccd361bb448be3529e6d1d6f","width":208,"height":277}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development, effective July 1, 2025.","length":312,"tagName":"p"},{"type":"text","content":""We are delighted to welcome Eric to the executive team,” said Thomas Zindrick, President, CEO, and Chairman of the Board. “Eric brings a powerful blend of legal expertise, global business development savvy, and a strategic understanding of the biotechnology ecosystem. His proven ability to lead high-impact transactions, build trusted partnerships, and navigate complex regulatory environments will be invaluable in shaping our next phase of growth.”","length":457,"tagName":"p"},{"type":"text","content":"Mr. Groen is an accomplished executive who has over two decades of leadership in the life sciences industry, driving results, empowering teams, and shaping positive corporate culture. ...